Virtu Financial’s INmune Bio INMB Stock Holding History

Virtu Financial’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,388	Closed	-$32K	–	1955
2025 Q4	$32K	Buy	+20,388	New	+$36.4K	﹤0.01%	1356
2025 Q3	–	Sell	-40,231	Closed	-$93K	–	1759
2025 Q2	$93K	Buy	+40,231	New	+$295K	﹤0.01%	1047
2022 Q1	–	Sell	-24,364	Closed	-$249K	–	1737
2021 Q4	$249K	Buy	+24,364	New	+$361K	0.03%	731
2021 Q3	–	Sell	-10,530	Closed	-$185K	–	1711
2021 Q2	$185K	Buy	+10,530	New	+$142K	0.02%	1031

Other funds holding INMB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's INMB Position: Q1 2026 in Review

Virtu Financial sold out of INmune Bio (INMB) in Q1 2026, closing a stake of 20,388 shares — an estimated $32K sold.

Virtu Financial first reported a position in INMB in Q2 2021 and held it in 4 quarters. The position peaked at $249K in Q4 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

Virtu Financial reported no remaining INmune Bio position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 20,388 INmune Bio shares in Q1 2026, an estimated $32K.
Virtu Financial first reported a position in INmune Bio in Q2 2021 and held it in 4 quarters.
Virtu Financial's INmune Bio position peaked at $249K in Q4 2021.
82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.